Kane Biotech Announces Grant of Stock Options

Not for distribution to U. S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 29, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announces that on May 28, 2026 it granted an aggregate of 9,750,000 stock options (the "Options") to certain directors, officers, employees and consultants of the Company in accordance with the Company's third amended and restated stock option plan.